ArticleDiagnostics (Basel, Switzerland)2023
ResRandSVM: Hybrid Approach for Acute Lymphocytic Leukemia Classification in Blood Smear Images.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 33 citations in OpenAlex.
- Demystifying Deep Learning Decisions in Leukemia Diagnostics Using Explainable AI.Diagnostics (Basel, Switzerland) · 2026Article
- Hybrid neutrosophic enhanced MobileNetV2 model for leukemia blood cell classification.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 2 countries.
Funding
Abstract
Acute Lymphocytic Leukemia is a type of cancer that occurs when abnormal white blood cells are produced in the bone marrow which do not function properly, crowding out healthy cells and weakening the immunity of the body and thus its ability to resist infections. It spreads quickly in children's bodies, and if not treated promptly it may lead to death. The manual detection of this disease is a tedious and slow task. Machine learning and deep learning techniques are faster than manual detection and more accurate. In this paper, a deep feature selection-based approach ResRandSVM is proposed for the detection of Acute Lymphocytic Leukemia in blood smear images. The proposed approach uses seven deep-learning models: ResNet152, VGG16, DenseNet121, MobileNetV2, InceptionV3, EfficientNetB0 and ResNet50 for deep feature extraction from blood smear images. After that, three feature selection methods are used to extract valuable and important features: analysis of variance (ANOVA), principal component analysis (PCA), and Random Forest. Then the selected feature map is fed to four different classifiers, Adaboost, Support Vector Machine, Artificial Neural Network and Naïve Bayes models, to classify the images into leukemia and normal images. The model performs best with a combination of ResNet50 as a feature extractor, Random Forest as feature selection and Support Vector Machine as a classifier with an accuracy of 0.900, precision of 0.902, recall of 0.957 and F1-score of 0.929.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.